The size of the Bone Growth Stimulators Market in Europe was worth USD 0.290 Billion in 2020 and estimated to be growing at a CAGR of 5.44% to reach USD 0.38 Billion by 2025 during the forecast period.
The bone growth stimulator market in Europe is driven by factors such as the growing elderly population, the increasing incidence of arthritis and sports injuries, and the rising demand for surgical methods non-invasive spinal cord. Initiative steps to create the popularity of these procedures by public and private organizations are ascribed to bolster the need for the market.
However, factors such as the immediate availability of other treatment options, questionable efficacy, problems encountered due to medical device problems, lack of awareness, and government support are hampering the demand for bone growth stimulator market.
This market research report has been segmented and sub-segmented into the following categories.
The CE and FDA support for SpinalStim and CervicalStimbone stimulation devices is anticipated to fuel the growth of bone growth stimulators market in Europe. The UK holds the most significant shares of the market with the increasing prevalence of effective treatment procedures. Germany and France are following the UK in leading the shares of the market. Increasing investments in the research and development activities in the medical sector are greatly influencing the demand of the market in these countries.
Companies dominating the Europe Bone Growth Stimulators Market are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Bone Growth Stimulation Devices
5.1.2.1 External Bone Growth Stimulators
5.1.2.2 Implanted Bone Growth Stimulators
5.1.2.3 Ultrasonic Bone Growth Stimulators
5.1.3 Bone Morphogenetic Proteins
5.1.4 Platelet-rich Plasma
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Spinal Fusion Surgeries
5.2.3 Delayed Union & Nonunion Bone Fractures
5.2.4 Other Applications
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals and Clinics
5.3.3 Home Care
5.3.4 Academic & Research Institutes
5.3.5 CROs
5.3.6 Y-o-Y Growth Analysis, By End user
5.3.7 Market Attractiveness Analysis, By End user
5.3.8 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End user
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 DJO LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Orthofix International N.V
8.3 Zimmer Biomet Holdings Inc
8.4 Elizur, Bioventus LLC
8.5 Ossatec Benelux BV
8.6 Verve Consulting Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
